#USA #Plano #Kidney Care #Value-Based Care #Kidneylink

Kidneylink: Setting the Standard in Value-Based Kidney Care

In a significant milestone for kidney care, Kidneylink has established itself as the leader in value-based kidney care savings, following the recent release of the 2024 Kidney Care Choices (KCC) Model results by the Centers for Medicare & Medicaid Innovation (CMMI). Founded in 2021 by a coalition of top nephrologists and U.S. Renal Care, Kidneylink operates 10 of the 80 Kidney Care Entities (KCEs) involved in the KCC Model, delivering exceptional care to 15,000 patients struggling with chronic kidney disease (CKD) and end-stage kidney disease (ESKD).

Industry-Leading Financial Savings

Kidneylink has achieved impressive reductions in total medical costs, establishing itself as the top performer across the KCC Model participants. With a Gross Savings of 6.4% (compared to the program average of 4.8%) and a Net Savings of 2.6% (against a benchmark of 1.9%), Kidneylink shows that its integrated, physician-aligned approach is both effective and transformative.

Mark Caputo, the company's Chief Executive Officer, voiced his enthusiasm: "These results mark a major leap forward in how care can – and should – be delivered. We're seeing significant reductions in avoidable complications and outstanding coordination across care settings. This is clear proof that our model is making a real difference."

A notable achievement this year was that 60% of Kidneylink's KCEs earned CMS distinction for their exceptional performance in quality metrics, such as delaying CKD progression and improving patient engagement and mortality rates.

Enhancing Patient-Centric Care

Kidneylink operates with a highly integrated model that emphasizes joint ventures with nephrologists, facilitating a seamless connection to clinical resources. By providing a team that includes nurse practitioners, care managers, pharmacists, dietitians, and others, Kidneylink supports patients holistically between medical appointments. This comprehensive approach allows for better patient management and enhanced outcomes.

Technological resources also play a pivotal role in Kidneylink's success. The Kidneylink360 population health platform delivers vital insights in real-time, which empower nephrologists to make informed decisions. This ensures the highest standard of care while streamlining clinical workflows and communication.

Alex Portet, Chief Operating Officer of Value-Based Care, highlighted, "When nephrologists have access to embedded care teams and real-time insights, it transforms patient outcomes. We are proud to collaborate with exemplary physicians, and these outcomes unequivocally support our shared model."

A Promising Future Ahead

Since its inception, Kidneylink has outperformed larger, long-standing competitors, demonstrating significant improvement year over year. The positive trends indicate that even stronger results are anticipated in the upcoming years. Notably, data shows that more than 60% of Kidneylink patients achieve optimal dialysis starts, significantly higher than the national average of only 30% among non-value-based care programs.

This early intervention and transitional care not only enhance patient confidence but also contribute to a $70,000 reduction in total annual costs for those who start treatment optimally versus those who face an unplanned, urgent dialysis entry.

Kidneylink's business model is expanding as it grows its partnerships with private payors, maintaining the same impressive results that have been observed in the CMS CKCC program. The company is well-positioned to deepen its impact and achieve even greater outcomes going forward.

For those looking to learn more about the innovative services provided by Kidneylink, visiting their website, Kidneylink.com, offers a comprehensive overview of their initiatives and partnerships in the healthcare space. Kidneylink continues to strengthen its position as a transformative force in kidney care, continually striving for excellence in both patient and financial outcomes.